As much as anyone watching the first US presidential debate between Donald Trump and Joe Biden can be said to be satisfied, the pharmaceutical industry should probably feel pretty good about the evening since they avoided much critical attention.
Any negative feelings generated from watching the 29 September debate were probably directed at the candidates, with Trump belligerently talking...